Cat. No. | Product name | CAS No. |
DC66051 | WAY-333449 Featured | 721964-46-1 |
DC66052 |
FGIN 1-43
Featured
FGIN 1-43 is an effective and specific ligand for the mitochondrial diazepam binding inhibitor (DBI) receptor (related to the production of neurosteroids). FGIN 1-43 enhances the transmission of GABA by inducing the production of neurosteroids, which can be used for research on anti-anxiety. |
145040-29-5 |
DC66053 | WAY-604663 Featured | 380347-87-5 |
DC66054 | WAY-639251 Featured | 796055-86-2 |
DC66055 |
WYE-175761
Featured
CTP inhibitor; Inhibitor of the mitochondrial citrate transport protein; |
92966-73-9 |
DC66056 |
Wnt/β-catenin agonist 4
Featured
Wnt/β-catenin agonist 4 (Derivative 83) is an agonist of Wnt that activates Wnt/β-catenin signal transmission. |
912784-79-3 |
DC66057 | 3,3'-(thiophen-2-ylmethylene)bis(2-methyl-1H-indole) Featured | 138801-72-6 |
DC66058 | 2-methoxy-5-(((3,4,5-trimethoxyphenyl)amino)methyl)phenyl (E)-but-2-enoate Featured | |
DC66059 | 2-(4-(Diethylamino)styryl)-1-methylpyridin-1-ium iodide Featured | 83846-70-2 |
DC66060 |
TC HSD 21
Featured
TC HSD 21 is a potent 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) inhibitor with an IC50 of 14 nM. TC HSD 21 shows excellent selectivity over 17β-HSD isoenzymes and nuclear receptors. |
330203-01-5 |
DC66061 |
WAY-301617
Featured
11b-hydroxysteroid dehydrogenase type 1 inhibitor |
311773-87-2 |
DC66062 | 2-(3-fluorophenyl)-3-phenylimidazo[1,2-a]pyridine Featured | 2706535-56-8 |
DC66063 | 1-([1,1'-biphenyl]-4-yl(4-fluorophenyl)methyl)-1H-imidazole Featured | 2901086-16-4 |
DC66064 |
WAY-656935
Featured
ROCK Inhibitor; inhibitor of ROCK, ERK, GSK, and AGC protein kinases; |
852902-81-9 |
DC66065 |
WAY-339495
Featured
Antitumor histone acetyl transferase inhibitors; modulator of acetyltransferase/deacetylase activity; sirtuin modulators; sirtuin modulators; sirtuin modulators; sirtuin modulators; sirtuin modulators; |
863589-28-0 |
DC66066 |
Transketolase-IN-4
Featured
Transketolase-IN-4 is a potent transketolase inhibitor (IC50=3.9 μM). Transketolase-IN-4 inhibits tumor cell proliferation of SW620, LS174T, and MIA PaCa-2. Transketolase-IN-4 is a possible Mycobacterium tuberculosis DXS inhibitor, with an IC50 value of 114.1 μM. |
419547-73-2 |
DC66067 |
BMY 14802
Featured
BMY 14802 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM. |
105565-56-8 |
DC66068 |
WAY-326275
Featured
inhibitor of lethal toxin pathway; useful for modulating hepatocyte growth factor/scatter factor activity; |
869873-21-2 |
DC66069 |
DAPK-IN-2
Featured
DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases. |
304000-05-3 |
DC66070 |
WAY-620472
Featured
altering the lifespan of a eukaryotic organism; PPAR modulator; |
686769-90-4 |
DC66071 |
4-Hydroxyretinoic acid
Featured
4-Hydroxyretinoic acid (4-HRA) is a naturally occurring retinoid derivative with diverse biological effects. 4-Hydroxyretinoic acid is formed from retinol catalyzed by cytochrome P-450 isozyme(s), and is mainly metabolized by the liver in the body. 4-Hydroxyretinoic acid also serves as the substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. 4-Hydroxyretinoic acid regulates gene expression and cell differentiation via binding to nuclear receptor RAR (Retinoic Acid Receptor), and activates RARs and RXR-alpha, to induce cancer cell apoptosis. In addition, 4-Hydroxyretinoic acid is also involved in various physiological processes such as immune regulation, neuroprotection, and anti-oxidation. |
66592-72-1 |
DC66072 |
TC-F2
Featured
TC-F2 is a reversible non-covalent binding inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 28 nM. FAAH is involved in many human diseases, particularly cancer, pain and inflammation as well as neurological, metabolic and cardiovascular disorders. |
1304778-15-1 |